Skip to content
stoqly

Coty

COTY NYSE Personal Care Products Financials FY2017–FY2026

Coty's revenue fell 1.5% to $5.8 billion in fiscal 2026. Its operating margin was −1.4%, down from 4.1% a year earlier. Free cash flow was $348 million, up 25.4%. It paid out $13 million in dividends and buybacks, 4% of free cash flow. The diluted share count rose 0.8%.

Last close · Oct 23, 2026

$3.23

0.6%
Value it Compare
Revenue Total sales reported in the income statement.
$5.8B
1.5% vs prior year
Operating margin Operating income as a share of revenue.
−1.4%
5.5 pts
Net income Profit after all expenses, interest and tax.
−$605M
Free cash flow Cash from operations minus capital spending.
$348M
25.4%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
−1.0%
3.5 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$2.8B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
—

What Coty does

No business description yet.

Legal name
COTY INC.
Fiscal year ends
June 30, 2026
Latest annual report
—
Accession · CIK
0001024305-26-000048
0001024305

Revenue and margins

Coty had $5.8B of revenue in fiscal 2026, down 1.5% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $348M in fiscal 2026, 6.0% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Coty returned $13.2M to shareholders in fiscal 2026, 4% of free cash flow. The diluted share count rose 0.8%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Coty yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of −$2.9B and divides by 877.4M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Balance sheet

Cash, debt and the ratios that show how comfortably Coty can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY22FY23FY24FY25FY26
Cash and short-term investments $233M$247M$301M$257M$176M
Debt incl. finance leases $4.5B$4.3B$3.9B$4.0B$3.1B
Net debt / EBITDA 5.6x4.2x3.7x5.7x7.3x
Debt / equity 1.4x1.1x1.0x1.1x1.0x
Interest coverage 1.0x2.1x2.2x1.1x−0.4x
Current ratio 0.7x0.8x0.8x0.8x0.8x
Quick ratio 0.4x0.4x0.5x0.5x0.4x
Total assets $12.1B$12.7B$12.1B$11.9B$10.2B
Total liabilities $8.6B$8.4B$7.8B$8.0B$6.8B
Shareholders' equity $3.2B$3.8B$3.8B$3.5B$3.0B
Net debt (− = net cash) $4.3B$4.0B$3.6B$3.8B$2.9B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.2M

2 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

—

$0.0M

DateInsiderTradeSharesPriceValueFiling
Mar 6, 2026 Bretten Gordon vonPresident - Consumer Beauty, Director Bought 83,000 $2.41 $0.2M Form 4
Feb 10, 2026 Laurent MercierChief Financial Officer Bought 5,000 $2.65 $0.0M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY24FY25FY26
Net income is positive ✓ ✕ ✕
Cash from operations is positive ✓ ✓ ✓
Return on assets rose ✕ ✕ ✕
Cash from operations exceeds net income ✓ ✓ ✓
Debt fell relative to assets ✓ ✕ ✓
Current ratio rose ✓ ✓ ✕
Share count didn't rise ✓ ✓ ✕
Gross margin rose ✓ ✓ ✕
Revenue rose relative to assets ✓ ✓ ✕
F-score 8 / 96 / 93 / 9
Accruals ratio −4.3%−7.2%−10.3%
Altman Z'' −0.83−1.14−1.85

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Coty COTY $2.8B −1.5% −1.4% 6.0% −1.0% — 3
Estée Lauder Companies EL $39.6B 5.1% 5.2% 8.7% 4.9% — 6 Compare →
Kenvue KVUE $37.6B −2.1% 16.0% 11.4% 10.0% 22.5x 6 Compare →
e.l.f. Beauty ELF $6.8B 24.6% 4.5% 11.6% 3.8% 114.2x 4 Compare →
Procter & Gamble PG $387.6B 3.3% 22.7% 17.4% 20.1% 24.3x 6 Compare →

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Income statement
Revenue $7.7B $6.8B $6.3B $4.7B $4.6B $5.3B $5.6B $6.1B $5.9B $5.8B
Gross profit $4.6B $4.1B $3.8B $2.7B $2.8B $3.4B $3.5B $3.9B $3.8B $3.7B
Research and development $139M $108M $98.5M $93.4M $96.5M $97.3M $105M $127M $123M $121M
Operating income −$421M −$156M −$3.7B −$1.2B −$48.6M $241M $544M $547M $241M −$81.5M
Interest expense $220M $223M $252M $233M $232M $241M $261M $252M $227M $184M
Pretax income −$658M −$395M −$3.9B −$1.5B −$240M $427M $705M $205M −$345M −$610M
Income tax −$260M −$32.2M −$54.8M −$378M −$172M $165M $182M $95.1M $5.4M −$20.0M
Net income −$422M −$169M −$3.8B −$1.0B −$201M $260M $508M $89.4M −$368M −$605M
Diluted EPS −$0.66 −$0.23 −$5.04 −$1.33 −$0.40 $0.08 $0.57 $0.09 −$0.44 −$0.70
Diluted shares 0.64B 0.75B 0.75B 0.76B 0.76B 0.83B 0.89B 0.88B 0.87B 0.88B
Cash flow
Cash from operations $758M $414M $640M −$50.9M $319M $727M $626M $615M $493M $538M
Capital expenditure $432M $446M $427M $267M $174M $174M $223M $245M $215M $190M
Free cash flow $325M −$32.7M $213M −$318M $145M $553M $403M $369M $278M $348M
Depreciation and amortization $555M $737M $736M $717M $585M $516M $427M $421M $420M $482M
Stock-based compensation $24.6M $30.6M $14.8M $29.8M $29.9M $196M $136M $88.8M $50.0M $46.3M
Acquisitions $743M $278M $40.8M $592M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Share buybacks $36.3M $0.0M $0.0M $4.5M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Dividends paid $373M $375M $345M $195M $25.7M $57.2M $13.7M $13.4M $13.3M $13.2M
Dividends and buybacks $409M $375M $345M $200M $25.7M $57.2M $13.7M $13.4M $13.3M $13.2M
Balance sheet
Cash and short-term investments $535M $332M $340M $308M $254M $233M $247M $301M $257M $176M
Total debt $7.2B $7.6B $7.8B $8.2B $5.5B $4.5B $4.3B $3.9B $4.0B $3.1B
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $7.1M $4.3M $9.7M $6.2M
Current assets $3.6B $3.7B $3.3B $6.5B $1.8B $1.7B $2.1B $2.0B $2.0B $1.9B
Current liabilities $3.8B $4.0B $3.5B $3.6B $2.4B $2.6B $2.7B $2.6B $2.5B $2.5B
Inventory $1.1B $1.1B $860M $678M $651M $662M $853M $764M $795M $839M
Property and equipment, net $1.6B $1.7B $1.3B $1.1B $918M $716M $713M $719M $709M $650M
Total assets $22.5B $22.6B $17.7B $16.7B $13.7B $12.1B $12.7B $12.1B $11.9B $10.2B
Total liabilities $12.7B $13.1B $12.7B $12.7B $9.5B $8.6B $8.4B $7.8B $8.0B $6.8B
Shareholders' equity $9.3B $8.8B $4.6B $3.0B $2.9B $3.2B $3.8B $3.8B $3.5B $3.0B
Margins
Gross margin 60.4% 60.3% 60.3% 57.8% 59.8% 63.5% 63.9% 64.4% 64.8% 62.9%
Operating margin −5.5% −2.3% −58.7% −26.2% −1.1% 4.5% 9.8% 8.9% 4.1% −1.4%
EBITDA margin 1.8% 8.5% −47.0% −11.0% 11.6% 14.3% 17.5% 15.8% 11.2% 6.9%
Net margin −5.5% −2.5% −60.2% −21.3% −4.4% 4.9% 9.2% 1.5% −6.2% −10.4%
FCF margin 4.3% −0.5% 3.4% −6.8% 3.1% 10.4% 7.3% 6.0% 4.7% 6.0%
Returns
Return on capital −3.3% −0.8% −20.7% −8.5% −0.4% 1.9% 5.2% 3.7% 2.5% −1.0%
Return on capital employed −3.5% −0.8% −22.5% −9.0% −0.4% 2.3% 5.6% 5.6% 2.6% −1.0%
Return on equity −8.7% −1.9% −56.3% −26.5% −6.9% 8.6% 14.6% 2.3% −10.0% −18.5%
Return on assets −2.9% −0.8% −18.8% −5.9% −1.3% 2.0% 4.1% 0.7% −3.1% −5.5%
Growth
Revenue growth 75.9% −10.6% −8.1% −25.0% −1.9% 14.6% 4.7% 10.2% −3.7% −1.5%
Net income growth −369.1% — — — — — 95.8% −82.4% −511.5% —
EPS growth −250.0% — — — — — 612.5% −84.2% −588.9% —
FCF growth −7.4% −110.1% — −249.4% — 281.6% −27.1% −8.3% −24.9% 25.4%
Share count change 81.5% 16.6% 0.2% 1.1% 0.8% 9.1% 6.3% −0.4% −1.4% 0.8%
Financial health
Net debt / EBITDA 49.8x 12.6x — — 9.7x 5.6x 4.2x 3.7x 5.7x 7.3x
Debt / equity 0.8x 0.9x 1.7x 2.7x 1.9x 1.4x 1.1x 1.0x 1.1x 1.0x
Interest coverage −1.9x −0.7x −14.6x −5.3x −0.2x 1.0x 2.1x 2.2x 1.1x −0.4x
Current ratio 0.9x 0.9x 0.9x 1.8x 0.7x 0.7x 0.8x 0.8x 0.8x 0.8x
Quick ratio 0.7x 0.6x 0.7x 1.6x 0.5x 0.4x 0.4x 0.5x 0.5x 0.4x
Capital allocation
Capex / revenue 5.7% 6.5% 6.8% 5.7% 3.8% 3.3% 4.0% 4.0% 3.7% 3.3%
Stock comp / revenue 0.3% 0.5% 0.2% 0.6% 0.7% 3.7% 2.5% 1.5% 0.9% 0.8%
Payouts / FCF 125.7% — 162.0% — 17.8% 10.4% 3.4% 3.6% 4.8% 3.8%
Quality scores
Piotroski F-score 5.0 4.0 3.0 3.0 6.0 7.0 8.0 8.0 6.0 3.0
Altman Z'' 0.5 0.5 −1.9 −0.2 −1.4 −1.4 −0.9 −0.8 −1.1 −1.9
Accruals ratio −8.0% −2.6% −21.9% −5.6% −3.4% −3.6% −1.0% −4.3% −7.2% −10.3%

Source: SEC EDGAR XBRL filings (CIK 0001024305). Data updated October 11, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open